Skip to main content
SpringerLink
Log in

Hepatotoxicity more likely with atorvastatin vs simvastatin

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Clarke AT, Johnson PCD, Hall GC, Ford I, Mills PR.High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin: a retrospective cohort study using the UK General Practice Research Database. 47th Annual Meeting of the European Association for the Study of the Liver: abstr. 1343, 18 Apr 2012. Available from: URL: http://mobile.ilcapp.eu/easl%5f161/poster%5f24709/program.aspx

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hepatotoxicity more likely with atorvastatin vs simvastatin. React. Wkly. 1406, 4 (2012). https://doi.org/10.2165/00128415-201214060-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201214060-00011

Keywords

Search

Navigation